Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.97B P/E - EPS this Y 1.70% Ern Qtrly Grth -
Income -802.69M Forward P/E -5.21 EPS next Y 19.20% 50D Avg Chg 8.00%
Sales 328.6M PEG - EPS past 5Y - 200D Avg Chg 13.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -25.00%
Recommedations 1.70 Quick Ratio 2.46 Shares Outstanding 171.85M 52W Low Chg 36.00%
Insider Own 0.95% ROA -24.77% Shares Float 160.98M Beta 1.11
Inst Own 111.20% ROE - Shares Shorted/Prior 13.50M/14.87M Price 21.77
Gross Margin 77.61% Profit Margin -244.27% Avg. Volume 979,658 Target Price 88.53
Oper. Margin -205.01% Earnings Date Oct 24 Volume 1,034,090 Change -1.63%
About Insmed Incorporated

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Insmed Incorporated News
09/06/24 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08/29/24 Insmed (INSM) Rose Due to Positive Trial Results
08/27/24 Insmed Stock Surges 168% in the Past Six Months: Here's Why
08/24/24 Meta Stock Leads 5 Names Near Buy Points As Market Bounces
08/14/24 Insider Sale: Chief People Strategy Officer Schaeffer Orlov S Nicole Sells Shares of Insmed Inc ...
08/11/24 Insmed Incorporated (NASDAQ:INSM) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
08/10/24 Insmed Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
08/09/24 Insmed (INSM) Lags on Q2 Earnings, Tops Sales, Reiterates View
08/09/24 Decoding Insmed Inc (INSM): A Strategic SWOT Insight
08/08/24 Compared to Estimates, Insmed (INSM) Q2 Earnings: A Look at Key Metrics
08/08/24 Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
08/08/24 Insmed: Q2 Earnings Snapshot
08/08/24 Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
07/31/24 Swelling losses haven't held back gains for Insmed (NASDAQ:INSM) shareholders since they're up 328% over 5 years
07/29/24 Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
07/29/24 Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024
07/25/24 These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini
07/25/24 Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
07/16/24 What Makes Insmed Incorporated (INSM) a Prospective Investment?
07/03/24 More endpoints met in Insmed’s Phase III brensocatib trial
INSM Chatroom

User Image GavinAlphaNavigator Posted - 1 day ago

$INSM

User Image HunterTrendPilot56 Posted - 2 days ago

$INSM

User Image Dy2ski Posted - 2 days ago

$INSM Decent Presentation at Today's Morgan Stanley Conference. Pretty strange that both CEO LEWIS and CFO Bonstein were not there representing. 🤔 CCO Wise, who gave the presentation said that they felt they were *ahead of schedule on the NDA for Brenso... *not much else specifically *new* but some action with Pillar 4 and DMD coming.

User Image StonkNomad Posted - 3 days ago

$INSM

User Image MarketSageX Posted - 3 days ago

$insm biotech sector strong, holding tight $veco tech stocks climbing, added on the dip $mynz holding for the long haul, potential massive

User Image JamesAlphaStrategist Posted - 3 days ago

$INSM

User Image Feero10 Posted - 4 days ago

$INSM 60 end of the week

User Image BullRunBanter59 Posted - 4 days ago

$INSM

User Image WillTrendMaster Posted - 4 days ago

$INSM

User Image DonCorleone77 Posted - 4 days ago

$INSM Insmed added to Americas Conviction List at Goldman Sachs Goldman Sachs analysts added Insmed to the firm's Americas Conviction List as part of its monthly update. Goldman has a Buy rating on Insmed with a $103 price target. The firm says Insmed is on the verge of becoming a three-tiered, multi-product, commercial-stage biotech company with an initial focus in rare pulmonary diseases. This inflection point has traditionally led to more predictable earnings and multiple expansion for biotech stocks, the analysts contend.

User Image SwingGuardianX99 Posted - 5 days ago

$INSM

User Image SwingGuardianX99 Posted - 5 days ago

$INSM

User Image Hendry884 Posted - 08/30/24

$INSM bought some lotto calls in case we hear some news post labor day.

User Image pianoman439 Posted - 08/30/24

$INSM I like what I see, what do you think?

User Image lemonhead1 Posted - 08/29/24

$MNKD investors jumping in that don’t want to miss out on the run like $INSM had

User Image Hendry884 Posted - 08/28/24

$INSM has the best asset rn among all xbi listed companies. Should get $20bil bo by EOY.

User Image Hendry884 Posted - 08/28/24

$IOVA $SWTX $INSM $VKTX Semi top. Slowing economy. You know where to invest.

User Image insidemoney Posted - 08/27/24

$INSM Insmed 14-Day RSI: 54.9 % from 52-Week Low: +254.6% % from 52-Week High: -6.6% Open Interest: 77,986 % Change: +3% Put/Call Ratio: 0.44 % Change: -5.4%

User Image MaverikIT Posted - 08/27/24

@IsabellaDC @net0trader @RonIsWrong bio$ $INSM

User Image insidemoney Posted - 08/26/24

$INSM Insmed 14-Day RSI: 65.4 % from 52-Week Low: +271.7% % from 52-Week High: -2.1% Open Interest: 75,577 % Change: +3% Put/Call Ratio: 1.41 % Change: -3.9%

User Image insidemoney Posted - 08/25/24

Options Volume (Aug 23) $INSM Insmed % Change -0.20% Trade Count 724 Total Notional 3.12 M 90 Day Average 2.4 M Calls 2.86 M Puts 260.6 K $WDC Western Digital % Change 0.50% Trade Count 2,839 Total Notional 3.08 M 90 Day Average 6.33 M Calls 2.71 M Puts 374.5 K

User Image dixiebull Posted - 08/24/24

$INSM tagged 80.50 at close then settled at vwap. See if 78 can hold now for a break of 80 to 83 $CVNA nice test of 160 Friday and holding well. Vwap is 157.50 area and if it can break 160 we can see 162.50 to 163 and 165 $BYON from prior watchlist ran to 11.57 and holding 11 so far. See if it can get volume for a move to 12 and 12.50 we will be watching bitcoin stocks and vaccine stocks as well, nice play on $MSTR and $COIN for the high priced stock players Friday

User Image Shypoker Posted - 08/23/24

$INSM https://finance.yahoo.com/news/insider-sale-chief-people-strategy-230137889.html

User Image SkSk_ Posted - 08/23/24

$INSM not normal trading the last week or so. Not even close. Thinking we have an M&A leak here.

User Image Stower Posted - 08/23/24

$INSM Hardy anything in Russell 2000 is down today, but of the few that are, INSM is largest of the losers. Usual to be sure.

User Image Cap1diot Posted - 08/23/24

$INSM looks way overpriced

User Image insidemoney Posted - 08/23/24

Options Volume (Aug 22) $ALGN Align Technology % Change -2.70% Trade Count 464 Total Notional 603.7 K 90 Day Average 1.79 M Calls 244.8 K Puts 359 K $INSM Insmed % Change 2.60% Trade Count 262 Total Notional 803.5 K 90 Day Average 2.39 M Calls 337.2 K Puts 466.3 K

User Image pianoman439 Posted - 08/22/24

$INSM 52-week closing high on a down day. Very promising!

User Image MaverikIT Posted - 08/22/24

@RonIsWrong @IsabellaDC @net0trader $INSM $SWTX $BMEA +1.17

User Image Hendry884 Posted - 08/22/24

$IOVA $VKTX $INSM all you need to hold

Analyst Ratings
HC Wainwright & Co. Buy Aug 29, 24
Truist Securities Buy Aug 12, 24
HC Wainwright & Co. Buy Aug 12, 24
TD Cowen Buy Aug 9, 24
UBS Buy Aug 9, 24
Stifel Buy Aug 9, 24
Morgan Stanley Overweight Jul 12, 24
Goldman Sachs Buy Jul 10, 24
Guggenheim Buy Jul 9, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wise John Drayton Chief Commercial Off.. Chief Commercial Officer Jan 03 Sell 29.26 21,238 621,424 115,690 01/05/24
Wise John Drayton Chief Commercial Off.. Chief Commercial Officer Jan 03 Option 19.11 20,071 383,557 124,055 01/05/24
Smith Michael Alexander General Counsel, Sen.. General Counsel, Senior VP Jan 04 Sell 29.31 627 18,377 88,737 01/05/24
Schaeffer Orlov S Nicole Chief People Strateg.. Chief People Strategy Officer Jan 04 Sell 29.28 1,457 42,661 105,149 01/05/24
Lewis William Chair and CEO Chair and CEO Jan 04 Sell 29.26 6,979 204,206 373,538 01/05/24
Flammer Martina M.D. Chief Medical Office.. Chief Medical Officer Jan 04 Sell 29.21 1,386 40,485 117,525 01/05/24
Adsett Roger Chief Operating Offi.. Chief Operating Officer Jan 04 Sell 29.21 3,042 88,857 161,183 01/05/24
Adsett Roger Chief Operating Offi.. Chief Operating Officer Jun 13 Sell 19.32 8,981 173,513 151,352 06/15/23
Wise John Drayton Chief Commercial Off.. Chief Commercial Officer Jan 10 Sell 17.96 779 13,991 77,272 01/12/23
Smith Michael Alexander General Counsel, Sen.. General Counsel, Senior VP Jan 10 Sell 17.93 1,836 32,919 54,332 01/12/23
Schaeffer Orlov S Nicole Chief People Strateg.. Chief People Strategy Officer Jan 10 Sell 17.95 2,435 43,708 72,159 01/12/23
Lewis William Chair and CEO Chair and CEO Jan 10 Sell 18 6,994 125,892 265,067 01/12/23
Flammer Martina M.D. Chief Medical Office.. Chief Medical Officer Jan 10 Sell 18.06 3,439 62,108 72,763 01/12/23
Bonstein Sara Chief Financial Offi.. Chief Financial Officer Jan 10 Sell 18.12 2,857 51,769 66,031 01/12/23
Adsett Roger Chief Operating Offi.. Chief Operating Officer Jan 10 Sell 17.99 3,194 57,460 135,487 01/12/23
Wise John Drayton Chief Commercial Off.. Chief Commercial Officer Nov 22 Sell 18.84 7,154 134,781 71,613 11/22/22
Adsett Roger Chief Operating Offi.. Chief Operating Officer Nov 22 Sell 18.80 11,855 222,874 134,127 11/22/22
SHAROKY MELVIN MD Director Director Oct 31 Buy 17.62 30,000 528,600 15,900 11/02/22
LEE LEO Director Director Oct 31 Buy 17.69 45,000 796,050 98,265 11/02/22
Smith Michael Alexander General Counsel, Sen.. General Counsel, Senior VP Jul 12 Sell 23.40 941 22,019 50,455 07/12/22
Lewis William Chair and CEO Chair and CEO Jul 07 Option 16.16 96,614 1,561,282 353,330 07/08/22
Lewis William Chair and CEO Chair and CEO Jul 07 Sell 23 96,614 2,222,122 256,716 07/08/22
SHAROKY MELVIN MD Director Director May 11 Buy 17.2 20,000 344,000 262,621 05/13/22
Lewis William Chair and CEO Chair and CEO Mar 23 Option 15.52 96,614 1,499,449 218,605 03/25/22
Lewis William Chair and CEO Chair and CEO Mar 23 Sell 23.31 96,614 2,252,072 217,624 03/25/22
Lewis William Chair&Chief Executiv.. Chair&Chief Executive Officer Nov 06 Option 6.24 235,000 1,466,400 164,787 11/06/20
Lewis William Chair&Chief Executiv.. Chair&Chief Executive Officer Nov 06 Sell 34.08 200,000 6,816,000 129,787 11/06/20
Pellizzari Christine A Chief Legal Officer Chief Legal Officer Nov 05 Option 12.19 183,450 2,236,256 134,002 11/05/20
Pellizzari Christine A Chief Legal Officer Chief Legal Officer Nov 05 Sell 33.01 143,796 4,746,706 94,348 11/05/20
SHAROKY MELVIN MD Director Director Sep 16 Sell 30.69 20,000 613,800 236,890 09/16/20